![]() |
|||||||||||||
|
All | Since 2019 | |
Citation | 5450 | 3969 |
h-index | 23 | 20 |
i10-index | 134 | 84 |
G1, G PROTEIN-COUPLED ESTROGEN RECEPTOR, SLOWDOWNS CHRONIC KIDNEY DISEASE DEVELOPMENT IN OVARIECTOMIZED MICE
Hala A. Ahmed*, Mirhan N. Makled, Tarek M. Ibrahim and Ahmed A. Shaaban
ABSTRACT
Cisplatin (CP) is a chemotherapy drug that is known to have a high incidence of nephropathy. Previous studies elucidated that G protein-coupled estrogen receptor (GPER) has a protective effect against renal toxicity. The purpose of this study is to look at the ability of G1, a GPER selective agonist, to slowdown chronic kidney disease (CKD) in ovariectomized (OVX) female mice. Female and OVX-female C57BL/6 mice received two cycles of 2.5 mg/kg CP with a 16-day free period in between (each cycle consists of 5 injections). G1 (50 or 100 μg/kg, i.p.) was given every day for 6 weeks. CP administration caused a significant decrease in body weight, kidney/body weight index, and total antioxidant capacity (TAC) concentration. In addition, CP administration resulted in histopathological changes in female group (p<0.05). Ovariectomy resulted in a more pronounced decrease in body weight, kidney/body weight index, and TAC concentration. In addition to more deterioration of histopathological changes in OVX-CP group Keywords: G1, Ovariectomy, Chronic kidney disease. [Download Article] [Download Certifiate] |